Document:

First Amendment to Supply Agreement, dated June 28, 2009

 Exhibit 10.28 
 FIRST AMENDMENT TO SUPPLY AGREEMENT 
 THIS FIRST AMENDMENT TO SUPPLY AGREEMENT (this “Amendment”) is made
and entered into effective as of June 28, 2009 (the “Effective Date”) by and between Cree Hong Kong Limited (formerly known as Cotco Luminant Device Limited) (“Seller”), a Hong Kong company with its principal offices at 3/F,
Photonics Centre, No. 2 Science Park East Avenue, Hong Kong Science Park, Shatin, Hong Kong, and Light Engine Ltd., a Hong Kong company with its principal place of business at 6/F, Photonics Centre, No. 2, Science Park East Avenue, Hong
Kong Science Park, Hong Kong (“Buyer”). 
 RECITALS 
 A. Seller and Buyer are parties to that certain Supply Agreement dated and effective as of March 30, 2007 (the “Agreement”). 

B. The parties wish to extend the term of the Agreement as described herein. 
 NOW, THEREFORE, in consideration of the premises and covenants and undertakings herein contained, the parties mutually agree as follows: 
  

	 	1.	Section 4.1(a) of the Agreement is hereby amended to extend the term of the Agreement through June 26, 2011. 

  

	 	2.	Except as amended hereby, the Agreement shall continue in full force and effect in accordance with its terms. 

 IN WITNESS WHEREOF, each of the parties hereto has caused this First Amendment to be executed by its duly authorized representative effective as of the Effective Date.

  

									
	 CREE HONG KONG LIMITED
	 		 	 LIGHT ENGINE LTD.

					
	 By:
	 	 /s/    RICHARD Y. T.
SY
	 		 	 By:
	 	 /s/    SIMON SUA

	 Name:
	 	 Richard Y. T. Sy
	 		 	 Name:
	 	 Simon Sua

	 Title:
	 	 Managing Director
	 		 	 Title:
	 	 Managing Director

	 Date:
	 	 July 2, 2009
	 		 	 Date:
	 	 July 6, 2009Convertible Subordinated Promissory Note Third Extension Agreement

 Exhibit 10.1 
 CONVERTIBLE SUBORDINATED PROMISSORY NOTE MATURITY DATE 
 THIRD EXTENSION AGREEMENT 
 Whereas, Bioject Medical Technologies Inc., an Oregon corporation (the “Company”), borrowed $508,896 from Life Sciences Opportunities Fund II (Institutional),
L.P., a Delaware Limited Partnership (the “Lender”), pursuant to that certain Convertible Subordinated Promissory Note, dated as of December 5, 2007 (the “Note”); and 
 Whereas, the Maturity Date of the Note was extended from May 15 2009 to July 15, 2009, pursuant to an Extension Agreement dated April 6, 2009, between the
Company and the Lender; and the Maturity Date of the Note was further extended from July 15, 2009 to August 15, 2009, pursuant to the Second Extension Agreement dated July 13, 2009, between the Company and the Lender; 
 Whereas, no principal and interest have been paid to date on the Note; and 
 Whereas, the Company has requested that the Lender extend the Maturity Date of the Note and all principal and interest due thereon to August 31, 2009; 
 For good and valuable consideration, the Company and the Lender agree as follow: 
 The Maturity Date of the Note is hereby
extended to August 31, 2009 and all principal and interest due and payable on the Note shall be due and payable on August 31, 2009 (the “Third Extension”). All of the other terms and conditions of the Note, the Convertible Note
Purchase and Warrant Agreement between the Company and the Lender dated as of December 5, 2007, as amended as of December 19, 2007, the Warrant to purchase 67,853 shares of the Company’s Common Stock issued by the Company to the
Lender on December 5, 2007 and the Registration Rights Agreement between the Company and the Lender dated as of December 5, 2007, shall remain in full force and effect and were not and are not amended in any manner by the Extension
Agreement, the Second Extension Agreement and this Third Extension Agreement. 
 Dated: August 14, 2009 
  

			
	LIFE SCIENCES OPPORTUNITIES FUND II (INSTITUTIONAL), L.P.
		
	By:	 	 /s/    Al Hansen

		 	Signet Healthcare Partners, LLC, General Partner
		 	Al Hansen, Managing Director
	
	Bioject Medical Technologies, Inc.
		
	By:	 	 /s/    Ralph Makar

		 	Ralph Makar
		 	President and Chief Executive Officer

 CONVERTIBLE SUBORDINATED PROMISSORY NOTE MATURITY DATE 
 THIRD EXTENSION AGREEMENT 
 Whereas, Bioject Medical
Technologies Inc., an Oregon corporation (the “Company”), borrowed $91,104 from Life Sciences Opportunities Fund II, L.P., a Delaware Limited Partnership (the “Lender”), pursuant to that certain Convertible Subordinated
Promissory Note, dated as of December 5, 2007 (the “Note”); and 
 Whereas, the Maturity Date of the Note was extended from May 15 2009
to July 15, 2009, pursuant to an Extension Agreement dated April 6, 2009, between the Company and the Lender; and the Maturity Date of the Note was further extended from July 15, 2009 to August 15, 2009, pursuant to the Second
Extension Agreement dated July 13, 2009, between the Company and the Lender; 
 Whereas, no principal and interest have been paid to date on the Note;
and 
 Whereas, the Company has requested that the Lender extend the Maturity Date of the Note and all principal and interest due thereon to August 31,
2009; 
 For good and valuable consideration, the Company and the Lender agree as follow: 
 The Maturity Date of the Note is hereby extended to August 31, 2009 and all principal and interest due and payable on the Note shall be due and payable on August 31, 2009 (the “Third Extension”).
All of the other terms and conditions of the Note, the Convertible Note Purchase and Warrant Agreement between the Company and the Lender dated as of December 5, 2007, as amended as of December 19, 2007, the Warrant to purchase 12,147
shares of the Company’s Common Stock issued by the Company to the Lender on December 5, 2007 and the Registration Rights Agreement between the Company and the Lender dated as of December 5, 2007, shall remain in full force and effect
and were not and are not amended in any manner by the Extension Agreement, the Second Extension Agreement and this Third Extension Agreement. 
  

			
	Dated: August 14, 2009
	
	LIFE SCIENCES OPPORTUNITIES FUND II, L.P.
		
	By:	 	 /s/    Al Hansen

		 	Signet Healthcare Partners, LLC, General Partner
		 	Al Hansen, Managing Director
	
	Bioject Medical Technologies, Inc.
		
	By:	 	 /s/    Ralph Makar

		 	Ralph Makar
		 	President and Chief Executive OfficerAmendment No. 2 to Employment Agreement (May)

 Exhibit 10.36 
 AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT 
 THIS AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (the
“Amendment”) is made this 12th day of August, 2009 between Gregg Appliances, Inc., an Indiana corporation (the “Company”), and Dennis L. May (the “Executive”). 
 WHEREAS, on October 19, 2004, the Company and the Executive entered into an Employment Agreement, which was subsequently amended by Amendment
No. 1 to Employment Agreement dated December 30, 2008 (the “Employment Agreement”); and 
 WHEREAS, the parties wish to
amend the Employment Agreement, effective as of August 5, 2009, to change the Executive’s title to President and Chief Executive Officer and to modify certain provisions relating to severance payable to the Executive if his employment is
involuntarily terminated by the Company without cause; 
 NOW, THEREFORE, in consideration of the premises and the mutual covenants herein
contained, the parties hereby amend the Employment Agreement, effective as of August 5, 2009, as follows: 
 1. Section 1(a) of the
Employment Agreement shall be deleted in its entirety and replaced with the following: 
 (a) General. The Company
hereby employs Executive, and Executive agrees, upon the terms and conditions herein set forth, to serve as the Company’s President and Chief Executive Officer. In such capacity, Executive shall perform such duties as may be delineated in the
by-laws of the Company, and such other duties as may be assigned to Executive from time to time by the Company’s Board of Directors. During the Period (as defined in paragraph 2 below), if Executive also serves as a member of the Company’s
Board of Directors he shall not be entitled to additional compensation for his service as a member of the Board. 
 2. Section 4(b)(i)
of the Employment Agreement shall be amended by deleting the last three sentences thereof. 
 3. Except as amended hereby, the terms and
conditions of the Employment Agreement shall continue unchanged and remain in full force and effect. 
 IN WITNESS WHEREOF, the Company and
the Executive have executed this Amendment effective as of the date above written. 
  

			
	GREGG APPLIANCES, INC.
		
	By:	 	/s/ Charlie Young
	Name:	 	Charlie Young
	Title:	 	Chief Human Resources Officer
		
	Dated:	 	8/12/09
	
	EXECUTIVE
		
		 	/s/ Dennis L. May
		 	Dennis L. May
		
	Dated:	 	8/12/09Amendment No. 3 to Employment Agreement (Throgmartin)

 Exhibit 10.37 
 AMENDMENT NO. 3 TO EMPLOYMENT AGREEMENT 
 THIS AMENDMENT NO. 3 TO EMPLOYMENT
AGREEMENT (this “Amendment”) is made this 12th day of August, 2009 between
Gregg Appliances, Inc., an Indiana corporation, hhgregg, Inc., a Delaware corporation, and Jerry W. Throgmartin (the “Executive”). 
 WHEREAS, Gregg Appliances, Inc. and Executive are parties to that certain Employment Agreement dated as of October 19, 2004, as amended pursuant to an Amendment to Employment Agreement dated as of April 12, 2007 between the
parties and hhgregg, Inc. and an Amendment No. 2 to Employment Agreement dated December 29, 2008 (the “Employment Agreement”); and 
 WHEREAS, the parties wish to further amend the Employment Agreement effective as of August 5, 2009 to reflect a change in Executive’s title; 
 NOW, THEREFORE, for and in consideration of the premises and the mutual covenants herein contained, the parties hereby amend the Employment Agreement,
effective as of August 5, 2009, as follows: 
 1. Section 1(a) of the Employment Agreement shall be deleted and replaced with the
following: 
 (a) General. The Company hereby employs Executive, and Executive agrees, upon the terms and conditions
herein set forth, to serve as the Executive Chairman of the Board of Directors of the Company. In such capacity, Executive shall perform such duties as may be delineated in the by-laws of the Company, and such other duties as may be assigned to
Executive from time to time by the Board of Directors of the Company. Executive shall also serve as Executive Chairman of the Board of Directors of hhgregg, Inc. (“hhgregg”), and in such capacity shall perform such duties as may be
delineated in the by-laws of hhgregg, and such other duties as may be assigned to Executive from time to time by the Board of Directors of hhgregg. 
 2. Except as amended hereby, the terms and conditions of the Employment Agreement shall continue unchanged and remain in full force and effect. 

 IN WITNESS WHEREOF, the Company, hhgregg, Inc. and the Executive have executed this Amendment effective
as of the date above written. 
  

			
	GREGG APPLIANCES, INC.
		
	By:	 	/s/ Charlie Young
	Name:	 	Charlie Young
	Title:	 	Chief Human Resources Officer
		
	Dated:	 	8/12/09
	
	hhgregg, Inc.
		
	By:	 	/s/ Charlie Young
	Name:	 	Charlie Young
	Title:	 	Chief Human Resources Officer
		
	Dated:	 	8/12/09
	
	EXECUTIVE
		
		 	/s/ Jerry W. Throgmartin
		 	Jerry W. Throgmartin
		
	Dated:	 	8/12/09

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00162-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00162-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00162-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00162-of-00352.parquet"}]]